Ask the doctor : the SSRI Controversy

By: Levitas, Andrew S.
Contributor(s): Hurley, Anne DesNoyers.
Series: Mental Health Aspects of Developmental Disabilities 8 (2) 2005: 61-67.Publisher: 2005Content type: text Media type: unmediated Carrier type: volume Subject(s): CHILDREN | INTELLECTUAL DISABILITY | DEVELOPMENTAL DISABILITIES | DEPRESSION | TREATMENT | DIAGNOSIS | PSYCHIATRIC DISORDERS | AUTISM | PSYCHOTROPIC DRUGS | POLITICS | AUTISM | SUICIDE | ADOLESCENTSSummary: Explains that the SSRI (specific serotonin reuptake inhibitors - used to treat some psychiatric disorders, particularly depression) controversy has arisen in the last two years, where government alerts in the UK, Canada and the US warned against the use of these for children and adolescents due to increased reports, in some studies, of suicide. Backgrounds the issues, discusses the politics involved and offers cautions in particular about undiagnosed depression in patients with autism spectrum disorders.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode Item holds
Article Research IHC Library Article (Browse shelf(Opens below)) Available (Article available on request) 22152
Total holds: 0

Explains that the SSRI (specific serotonin reuptake inhibitors - used to treat some psychiatric disorders, particularly depression) controversy has arisen in the last two years, where government alerts in the UK, Canada and the US warned against the use of these for children and adolescents due to increased reports, in some studies, of suicide. Backgrounds the issues, discusses the politics involved and offers cautions in particular about undiagnosed depression in patients with autism spectrum disorders.

There are no comments on this title.

to post a comment.

Powered by Koha